Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French FastSeal Bioabsorbable Vascular Access Closure System, achieving a 100 percent success rate throughout both phases of the clinical trial, with exceptional time to hemostasis (TTH) and time to ambulation (TTA).

The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers and patients about a change to the container and carton labels for heparin products.

Siemens, syngo.MR Cardiac 4-D, MRI software

Increasingly software applications are providing many of the major advancements in magnetic resonance imaging (MRI) rather than hardware. In recent years, this has translated into software that enables physicians to do more in less time, extract more diagnostic information from imaging exams and provide more accurate quantification. While a hospital may not spend millions to upgrade its MRI system, it frequently takes advantage of the lower cost option of other vendors’ software to assess and manipulate those images. 

Two key news items in September made me think about the future direction of hemodynamic support, and that 


Two key news items in September made me think about the future direction of hemodynamic support, and that intra-aortic balloon pumps (IABP) will increasingly face a more serious challenge from small percutaneous left ventricular assist devices (pLVAD).  This was reinforced when I received a cardiology market analysis from GlobalData agreeing with this assessment.
GE Healthcare, Silent scan, noiseless MRI
Volpara, breast density
Toshiba, 640-slice, CT scanner, Aquilion One Vision
flexible MRI coils

There were several evident trends on the show floor at RSNA 2012, including interest in software fueled by Stage 1 and 2 meaningful use requirements, new mammography solutions and innovations in imaging hardware.

 

More than half of patients treated for claudication or critical limb ischemia (CLI) with stenting of the superficial femoral artery (SFA) had primary patency at five years, says a recent study.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now